BioCardia, Inc. (BCDA)

NASDAQ: BCDA · IEX Real-Time Price · USD
1.49
0.00 (-0.34%)
Jul 6, 2022 4:30 PM EDT - Market closed

Stock Price Forecast

According to 11 stock analysts, the average 12-month stock price forecast for BioCardia stock is $8.67, which predicts an increase of 483.84%. The lowest target is $3.03 and the highest is $15.75. On average, analysts rate BioCardia stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $3.03 $8.67 $9.18 $15.75
Change +104.04% +483.84% +518.18% +960.61%

Analyst Ratings

The average analyst rating for BioCardia stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 222222
Buy 778888
Hold 211111
Sell 000000
Strong Sell 000000
Total 111011111111

Financial Forecast

Revenue This Year
624.24K
Decreased by -38.50%
Revenue Next Year
186.92K
Decreased by -70.06%
EPS This Year
-0.88
EPS Next Year
-0.79
Year 2017201820192020202120222023202420252026
Revenue
479.00K625.00K710.00K145.00K1.02M624.24K186.92K2.41M5.91M14.77M
Revenue Growth
-16.84%
30.48%
13.60%
-79.58%
600.00%
-38.50%
-70.06%
1,189.22%
145.10%
150.00%
EPS
-2.90-3.28-2.61-1.48-0.75-0.88-0.79-0.69-0.76-0.84
EPS Growth
----------
No. Analysts -----66622

Revenue Forecast

Revenue 20222023202420252026
High 1.6M 656,250 9.1M 6.2M 15.4M
Avg 624,240 186,915 2.4M 5.9M 14.8M
Low n/a n/a n/a 5.7M 14.3M

Revenue Growth

Revenue Growth 20222023202420252026
High
118.7%
5.1%
4,790.1%
157.4%
160.0%
Avg
-13.3%
-70.1%
1,189.2%
145.1%
150.0%
Low - - -
137.7%
142.5%

EPS Forecast

EPS 20222023202420252026
High -0.77 -0.60 -0.32 -0.79 -0.87
Avg -0.88 -0.79 -0.69 -0.76 -0.84
Low -1.06 -0.91 -0.93 -0.73 -0.81

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -